Since either of the components of oxykine, that is, melon-derived SOD or gliadin, does not have the ability to induce Mn-SOD by itself, the oxykine formulation composed of melon-derived SOD and covered with gliadin was thought necessary to induce preventive effects on the inflammation-induced tumour progression. The gene discussed is SOD1; the disease is neoplasm.